TI
IONS icon

Tidal Investments’s Ionis Pharmaceuticals IONS Stock Holding History

Tidal Investments’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.9M Buy
49,178
+14,746
+43% +$1.11M 0.01% 1037
2026
Q1 		$2.51M Buy
34,432
+16,524
+92% +$1.3M 0.01% 1076
2025
Q4 		$1.42M Buy
+17,908
New +$1.35M ﹤0.01% 1091
2025
Q2 		– Sell
-21,833
Closed -$659K – 1986
2025
Q1 		$659K Buy
21,833
+4,426
+25% +$145K 0.01% 1175
2024
Q4 		$609K Sell
17,407
-1,501
-8% -$56.1K ﹤0.01% 1277
2024
Q3 		$757K Sell
18,908
-42
-0.2% -$1.95K 0.01% 1151
2024
Q2 		$903K Sell
18,950
-1,455
-7% -$59.7K 0.01% 951
2024
Q1 		$885K Buy
+20,405
New +$973K 0.01% 929
2023
Q4 		– Sell
-4,427
Closed -$201K – 1469
2023
Q3 		$201K Buy
+4,427
New +$183K 0.01% 1220
2022
Q4 		– Sell
-4,667
Closed -$206K – 1157
2022
Q3 		$206K Sell
4,667
-2,940
-39% -$124K 0.01% 948
2022
Q2 		$282K Buy
7,607
+2,030
+36% +$76.5K 0.01% 802
2022
Q1 		$207K Buy
+5,577
New +$183K 0.01% 1007

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Tidal Investments's IONS Position: Q2 2026 in Review

Tidal Investments increased its Ionis Pharmaceuticals (IONS) stake by 43% in Q2 2026, buying an estimated $1.11M and bringing the position to 49,178 shares worth $3.9M. The position accounts for 0.01% of the portfolio, ranked #1037.

Tidal Investments first reported a position in IONS in Q1 2022 and has held it in 12 quarters since. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Tidal Investments held 49,178 shares of Ionis Pharmaceuticals worth $3.9M as of Q2 2026.
  • Tidal Investments bought 14,746 Ionis Pharmaceuticals shares in Q2 2026, an estimated $1.11M.
  • Ionis Pharmaceuticals made up 0.01% of Tidal Investments's portfolio in Q2 2026, its #1037 holding.
  • Tidal Investments first reported a position in Ionis Pharmaceuticals in Q1 2022 and has held it in 12 quarters since.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.